2025. Evaluating Knowledge And Awareness Of SGLT-2 Inhibitors’ Use, Efficacy, Side Effects, And Cardiovascular And Renal Impacts Among Primary Healthcare Physicians In Makkah, Saudi Arabia. The Review of Diabetic Studies . (Jun. 2025), 490–500. DOI:https://doi.org/10.70082/rr96vh76.